BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38176415)

  • 1. OXCT1 functions as a succinyltransferase, contributing to hepatocellular carcinoma via succinylating LACTB.
    Ma W; Sun Y; Yan R; Zhang P; Shen S; Lu H; Zhou Z; Jiang Z; Ye L; Mao Q; Xiong N; Jia W; Sun L; Gao P; Zhang H
    Mol Cell; 2024 Feb; 84(3):538-551.e7. PubMed ID: 38176415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for identifying OXCT1-mediated LACTB succinylation sites in vitro.
    Ma W; Sun Y; Zhang H
    STAR Protoc; 2024 Jun; 5(2):103088. PubMed ID: 38787728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LACTB, a Metabolic Therapeutic Target in Clinical Cancer Application.
    Li X; Ren Z; Huang X; Yu T
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein succinylation associated with the progress of hepatocellular carcinoma.
    Bai W; Cheng L; Xiong L; Wang M; Liu H; Yu K; Wang W
    J Cell Mol Med; 2022 Nov; 26(22):5702-5712. PubMed ID: 36308411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of LACTB, a Mitochondrial Protein That Inhibits Proliferation and Invasion in Glioma Cells.
    Li HT; Dong DY; Liu Q; Xu YQ; Chen L
    Oncol Res; 2019 Mar; 27(4):423-429. PubMed ID: 28835318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the mechanism of succinylation in cancer.
    Lu K; Han D
    Medicine (Baltimore); 2022 Nov; 101(45):e31493. PubMed ID: 36397343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
    Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
    Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
    Xie J; Peng Y; Chen X; Li Q; Jian B; Wen Z; Liu S
    PLoS One; 2021; 16(1):e0245908. PubMed ID: 33507917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of the human LACTB filament reveals the mechanisms of assembly and membrane binding.
    Bennett JA; Steward LR; Rudolph J; Voss AP; Aydin H
    PLoS Biol; 2022 Dec; 20(12):e3001899. PubMed ID: 36534696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8
    Zhu CX; Yan K; Chen L; Huang RR; Bian ZH; Wei HR; Gu XM; Zhao YY; Liu MC; Suo CX; Li ZK; Yang ZY; Lu MQ; Hua XF; Li L; Zhao ZB; Sun LC; Zhang HF; Gao P; Lian ZX
    J Hepatol; 2024 May; ():. PubMed ID: 38759889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezh2 promotes TRβ lysine methylation-mediated degradation in hepatocellular carcinoma.
    Park SC; Lee JM
    Genes Genomics; 2022 Mar; 44(3):369-377. PubMed ID: 34851506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LACTB exerts tumor suppressor properties in epithelial ovarian cancer through regulation of Slug.
    Cutano V; Ferreira Mendes JM; Escudeiro-Lopes S; Machado S; Vinaixa Forner J; Gonzales-Morena JM; Prevorovsky M; Zemlianski V; Feng Y; Kralova Viziova P; Hartmanova A; Malcekova B; Jakoube P; Iyer S; Keckesova Z
    Life Sci Alliance; 2023 Jan; 6(1):. PubMed ID: 36375842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LACTB suppresses melanoma progression by attenuating PP1A and YAP interaction.
    Ma Y; Wang L; He F; Yang J; Ding Y; Ge S; Fan X; Zhou Y; Xu X; Jia R
    Cancer Lett; 2021 May; 506():67-82. PubMed ID: 33675985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling the Function of the Mitochondrial Filament-Forming Protein LACTB in Lipid Metabolism and Cancer.
    Cascone A; Lalowski M; Lindholm D; Eriksson O
    Cells; 2022 May; 11(10):. PubMed ID: 35626737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of LACTB promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma.
    Xue C; He Y; Zhu W; Chen X; Yu Y; Hu Q; Chen J; Liu L; Ren F; Ren Z; Cui G; Sun R
    Am J Transl Res; 2018; 10(12):4152-4162. PubMed ID: 30662658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of β-Lactamase Expression in Colorectal Cancer.
    Zhou S; Miao L; Li T; Liu P; Zhou H
    Cancer Biother Radiopharm; 2022 Dec; 37(10):939-944. PubMed ID: 33259719
    [No Abstract]   [Full Text] [Related]  

  • 17. Tandem mass tag-based quantitative proteomic analysis identification of succinylation related proteins in pathogenesis of thoracic aortic aneurysm and aortic dissection.
    Zhang Y; Zhang H; Wang H; Wang C; Yang P; Lu C; Liu Y; Xu Z; Xie Y; Hu J
    PeerJ; 2023; 11():e15258. PubMed ID: 37193023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
    Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
    Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
    [No Abstract]   [Full Text] [Related]  

  • 19. LACTB is a filament-forming protein localized in mitochondria.
    Polianskyte Z; Peitsaro N; Dapkunas A; Liobikas J; Soliymani R; Lalowski M; Speer O; Seitsonen J; Butcher S; Cereghetti GM; Linder MD; Merckel M; Thompson J; Eriksson O
    Proc Natl Acad Sci U S A; 2009 Nov; 106(45):18960-5. PubMed ID: 19858488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survival.
    Peng LX; Wang MD; Xie P; Yang JP; Sun R; Zheng LS; Mei Y; Meng DF; Peng XS; Lang YH; Qiang YY; Li CZ; Xu L; Liu ZJ; Guo LL; Xie DH; Shu DT; Lin ST; Luo FF; Huang BJ; Qian CN
    Cancer Lett; 2021 Feb; 498():165-177. PubMed ID: 33152401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.